| Application no. and date | 16852866.9 (espacenet) (Federated) (European Patent Register), 20161208 | | Patent/reg. no. and date | DK/EP 3386531, 20211013 | | Publication date | 20181017 | | Priority no. and date | US 201562264682 P, 20151208 | | EP pub. no. and date |
EP 3386531 20181017 | | Effective date | | | Applicant/owner | BioMarin Pharmaceutical Inc., 105 Digital Drive
Novato, CA 94949, US | | Applicant ref. no. | 1619131 | | Inventor | O'NEILL, Charles, A., 105 Digital Drive
Novato
CA 94949, US,
OPPENEER, Todd, M., 105 Digital Drive
Novato
CA 94949, US,
PINKSTAFF, Jason, K., 105 Digital Drive
Novato
CA 94949, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/22 (2006.01) , A61P 19/02 (2006.01) | | Title | ANVENDELSE AF C-TYPE NATRIURETISKE PEPTIDVARIANTER TIL BEHANDLING AF OSTEOARTHRITIS | | Int. application no. | US2016065520 | | Int. publication no. | WO2017100400 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
